Neutropenia and primary immunodeficiency diseases

International Reviews of Immunology

Volumn 28, Issue 5, 2009, Pages 335-366

  Rezaei, Nima ^a,b   Moazzami, Kasra ^b   Aghamohammadi, Asghar ^a,b   Klein, Christoph ^c  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

mutation; neutropenia; neutrophil granulocytes; primary immunodeficiency diseases; severe congenital neutropenia; susceptibility to infection

Indexed keywords

CD40 LIGAND; GRANULOCYTE COLONY STIMULATING FACTOR; PROTEIN P14;

ACUTE GRANULOCYTIC LEUKEMIA; AGAMMAGLOBULINEMIA; APHTHOUS STOMATITIS; AUTOIMMUNE DISEASE; AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME; AUTOIMMUNITY; B LYMPHOCYTE; BARTH SYNDROME; BONE MARROW; CARTILAGE HAIR HYPOPLASIA; CD40 LIGAND DEFICIENCY; CELL CYCLE ARREST; CELL DIFFERENTIATION; CHEDIAK HIGASHI SYNDROME; COHEN SYNDROME; DYSKERATOSIS CONGENITA; GENE CONTROL; GENE MUTATION; GENETIC ASSOCIATION; GENETIC DISORDER; GENETIC SUSCEPTIBILITY; GINGIVA HYPERPLASIA; GLYCOGEN STORAGE DISEASE TYPE 1; GLYCOGEN STORAGE DISEASE TYPE 1B; GRISCELLI SYNDROME; GRISCELLI SYNDROME TYPE 2; HAIR DISEASE; HEMATOLOGIC DISEASE; HERMANSKY PUDLAK SYNDROME TYPE 2; HUMAN; IMMUNE DEFICIENCY; LEUKEMOGENESIS; MYELODYSPLASTIC SYNDROME; NEOPLASM; NEUTROPENIA; NEUTROPHIL; NONHUMAN; OCULAR ALBINISM; PATHOPHYSIOLOGY; PRIMARY IMMUNODEFICIENCY DISEASE; PRIORITY JOURNAL; PROTEIN DEFICIENCY; PROTEIN P14 DEFICIENCY; PURINE NUCLEOSIDE PHOSPHORYLASE DEFICIENCY; RETICULAR DYSGENESIS; REVIEW; SEVERE CONGENITAL NEUTROPENIA; SHWACHMAN SYNDROME; SPLENOMEGALY; VIRUS INFECTION; WART, HYPOGAMMAGLOBULINEMIA, INFECTION, AND MYELOKATHEXIS SYNDROME; WISKOTT ALDRICH SYNDROME; X LINKED HYPER IMMUNOGLOBULIN M SYNDROME; GENETICS; IMMUNOLOGY;

HUMANS; IMMUNOLOGIC DEFICIENCY SYNDROMES; NEUTROPENIA;

EID: 73349099029     PISSN: 08830185     EISSN: 15635244     Source Type: Journal    
DOI: 10.1080/08830180902995645     Document Type: Review

References (202)

1. N. Rezaei, F.A. Bonilla, K.E. Sullivan, E. de Vries, and J.S. Orange. An introduction to primary immunodeficiency diseases. In: N. Rezaei, A. Aghamohammadi, and L.D. Notarangelo (Eds.). Primary Immunodeficiency Diseases: Definition, Diagnosis and Management. Berlin Heidelberg: Springer-Verlag, pp. 1-38, 2008.
2. R.S. Geha, L.D. Notarangelo, J.L. Casanova, H. Chapel, M.E. Conley, A. Fischer, et al. Primary immunodeficiency diseases: An update from the International Union of Immunological Societies Primary Immunodeficiency Diseases Classification Committee. J Allergy Clin Immunol 120: 776-794, 2007.
3. A. Aghamohammadi, M. Moein, A. Farhoudi, Z. Pourpak, N. Rezaei, K. Abolmaali, et al. Primary immunodeficiency in Iran: First report of the National Registry of PID in Children and Adults. J Clin Immunol 22: 375-380, 2002. (Pubitemid 35305887)
4. N. Rezaei, M. Moin, Z. Pourpak, A. Ramyar, M. Izadyar, Z. Chavoshzadeh, et al. The clinical, immunohematological, and molecular study of Iranian patients with severe congenital neutropenia. J Clin Immunol 27: 525-533, 2007. (Pubitemid 47319259)
5. P.D. Arkwright, M. Abinun, and A.J. Cant. Autoimmunity in human primary immunodeficiency diseases. Blood 99: 2694-2702, 2002. (Pubitemid 34525354)
6. C. Cunningham-Rundles. Hematologic complications of primary immune deficiencies. Blood Rev 16: 61-64, 2002. (Pubitemid 34293557)
7. C.L. Constantinou. Differential diagnosis of neutropenia. In: A. Tefferi (Ed.). Primary Hematology. Totowa, NJ: Humana Press, pp. 93-105, 2001.
8. B. Cham, M.A. Bonilla, and J. Winkelstein. Neutropenia associated with primary immunodeficiency syndromes. Semin Hematol 39: 107-112, 2002. (Pubitemid 34298834)
9. N. Rezaei, A. Farhoudi, Z. Pourpak, A. Aghamohammadi, M. Moin, M. Movahedi, and M. Gharagozlou. Neutropenia in Iranian patients with primary immunodeficiency disorders. Haematologica 90: 554-556, 2005. (Pubitemid 40592902)
10. G. Bohn, K.Welte, and C. Klein. Severe congenital neutropenia: New genes explain an old disease. Curr Opin Rheumatol 19: 644-650, 2007. (Pubitemid 47530887)
11. A.A. Schaffer and C. Klein. Genetic heterogeneity in severe congenital neutropenia: How many aberrant pathways can kill a neutrophil? Curr Opin Allergy Clin Immunol 7: 481-494, 2007. (Pubitemid 350076443)
12. K. Boztug, K. Welte, C. Zeidler, and C. Klein. Congenital neutropenia syndromes. Immunol Allergy Clin North Am 28: 259-275, vii-viii, 2008. (Pubitemid 351522409)
13. K.Welte, C. Zeidler, and D.C. Dale. Severe congenital neutropenia. Semin Hematol 43: 189-195, 2006. (Pubitemid 43963504)
14. J. Skokowa, M. Germeshausen, C. Zeidler, and K. Welte. Severe congenital neutropenia: Inheritance and pathophysiology. Curr Opin Hematol 14: 22-28, 2007. (Pubitemid 44885608)
15. U. Wintergerst, S.D. Rosenzweig, M. Abinun, H.L. Malech, S.M. Holland, and N. Rezaei. Phagocytes defects. In: N. Rezaei, A. Aghamohammadi, and L.D. Notarangelo (Ed.). Primary Immunodeficiency Diseases: Definition, Diagnosis and Management. Berlin Heidelberg: Springer-Verlag, pp. 1-38, 2008.
16. D.C. Dale, A.A. Bolyard, B.G. Schwinzer, G. Pracht, M.A. Bonilla, L. Boxer, et al. The Severe Chronic Neutropenia International Registry: 10-Year Follow-up Report. Support Cancer Ther 3: 220-231, 2006. (Pubitemid 44521081)
17. N. Rezaei, A. Farhoudi, A. Ramyar, Z. Pourpak, A. Aghamohammadi, B. Mohammadpour, et al. Congenital neutropenia and primary immunodeficiency disorders: A survey of 26 Iranian patients. J Pediatr Hematol Oncol 27: 351-356, 2005. (Pubitemid 41077022)
18. A. Fahimzad, Z. Chavoshzadeh, H. Abdollahpour, C. Klein, and N. Rezaei. Necrosis of nasal cartilage due to mucormycosis in a patient with severe congenital neutropenia due to HAX1 deficiency. J Investig Allergol Clin Immunol 18: 469-472, 2008.
19. M. Germeshausen, M. Grudzien, C. Zeidler, H. Abdollahpour, S. Yetgin, N. Rezaei, et al. Novel HAX1 mutations in patients with severe congenital neutropenia reveal isoform-dependent genotype-phenotype associations. Blood 111: 4954-4957, 2008.
20. N. Rezaei, Z. Chavoshzadeh, R.A. O. I. Sandrock, and C. Klein. Association of HAX1 deficiency with neurological disorder. Neuropediatrics 38: 261-263, 2007. (Pubitemid 351462133)
21. N. Ishikawa, S. Okada, M. Miki, K. Shirao, H. Kihara, M. Tsumura, et al. Neurodevelopmental abnormalities associated with severe congenital neutropenia due to the R86X mutation in the HAX1 gene. J Med Genet 45: 802-807, 2008.
22. K. Boztug, G. Appaswamy, A. Ashikov, A.A. Schäffer, U. Salzer, J. Diestelhorst, et al. A syndrome with congenital neutropenia and mutations in G6PC3. N Engl J Med 360: 32-43, 2009.
23. A.C. Ward and D.C. Dale. Genetic and molecular diagnosis of severe congenital neutropenia. Curr Opin Hematol 16: 9-13, 2009.
24. D.C. Dale, R.E. Person, A.A. Bolyard, A.G. Aprikyan, C. Bos, M.A. Bonilla, et al. Mutations in the gene encoding neutrophil elastase in congenital and cyclic neutropenia. Blood 96: 2317-2322, 2000.
25. J. Xia, A.A. Bolyard, E. Rodger, S. Stein, A.A.G. Aprikyan, D.C. Dale, and D.C. Link. Incidence of SCN-associated gene mutations in severe congenital neutropenia patients in North America. In: 50th American Society of Hematology Annual Meeting, 2008.
26. C. Bellanne-Chantelot, S. Clauin, T. Leblanc, B. Cassinat, F. Rodrigues-Lima, S. Beaufils, et al. Mutations in the ELA2 gene correlate with more severe expression of neutropenia: A study of 81 patients from the French Neutropenia Register. Blood 103: 4119-4125, 2004. (Pubitemid 38685352)
27. H. Takahashi, T. Nukiwa, P. Basset, and R.G. Crystal. Myelomonocytic cell lineage expression of the neutrophil elastase gene. J Biol Chem 263: 2543-2547, 1988. (Pubitemid 18060324)
28. S.J. Salipante, K.F. Benson, J. Luty, V. Hadavi, R. Kariminejad, M.H. Kariminejad, et al. Double de novo mutations of ELA2 in cyclic and severe congenital neutropenia. Hum Mutat 28: 874-881, 2007. (Pubitemid 47579937)
29. I. Kollner, B. Sodeik, S. Schreek, H. Heyn, N. von Neuhoff, M. Germeshausen, et al. Mutations in neutrophil elastase causing congenital neutropenia lead to cytoplasmic protein accumulation and induction of the unfolded protein response. Blood 108: 493-500, 2006. (Pubitemid 44061347)
30. D.S. Grenda,M.Murakami, J. Ghatak, J. Xia, L.A. Boxer, D. Dale, et al.Mutations of the ELA2 gene found in patients with severe congenital neutropenia induce the unfolded protein response and cellular apoptosis. Blood 110: 4179-4187, 2007. (Pubitemid 351377781)
31. J. Xia and D.C. Link. Severe congenital neutropenia and the unfolded protein response. Curr Opin Hematol 15: 1-7, 2008. (Pubitemid 350191022)
32. K.F. Benson, F.Q. Li, R.E. Person, D. Albani, Z. Duan, J.Wechsler, et al. Mutations associated with neutropenia in dogs and humans disrupt intracellular transport of neutrophil elastase. Nat Genet 35: 90-96, 2003. (Pubitemid 37048601)
33. M. Horwitz, K.F. Benson, Z. Duan, F.Q. Li, and R.E. Person. Hereditary neutropenia: Dogs explain human neutrophil elastase mutations. Trends Mol Med 10: 163-170, 2004. (Pubitemid 38410974)
34. A.A. Aprikyan, T. Kutyavin, S. Stein, P. Aprikian, E. Rodger, W.C. Liles, et al. Cellular and molecular abnormalities in severe congenital neutropenia predisposing to leukemia. Exp Hematol 31: 372-381, 2003. (Pubitemid 36579362)
35. C. Klein, M. Grudzien, G. Appaswamy, M. Germeshausen, I. Sandrock, A.A. Schaffer, et al. HAX1 deficiency causes autosomal recessive severe congenital neutropenia (Kostmann disease). Nat Genet 39: 86-92, 2007. (Pubitemid 46026506)
36. Y. Suzuki, C. Demoliere, D. Kitamura, H. Takeshita,U. Deuschle, and T.Watanabe. HAX-1, a novel intracellular protein, localized onmitochondria, directly associates with HS1, a substrate of Src family tyrosine kinases. J Immunol 158: 2736-2744, 1997. (Pubitemid 127470532)
37. A.R. Gallagher, A. Cedzich, N. Gretz, S. Somlo, and R. Witzgall. The polycystic kidney disease protein PKD2 interacts with Hax-1, a protein associated with the actin cytoskeleton. Proc Natl Acad Sci U S A 97: 4017-4022, 2000. (Pubitemid 30226079)
38. V. Radhika, D. Onesime, J.H. Ha, and N. Dhanasekaran. Galpha13 stimulates cell migration through cortactin-interacting protein Hax-1. J Biol Chem 279: 49406-49413, 2004. (Pubitemid 39625826)
39. J.R. Chao, E. Parganas, K. Boyd, C.Y. Hong, J.T. Opferman, and J.N. Ihle. Hax1- mediated processing of HtrA2 by Parl allows survival of lymphocytes and neurons. Nature 452: 98-102, 2008. (Pubitemid 351355088)
40. K. Devriendt, A.S. Kim, G. Mathijs, S.G. Frints, M. Schwartz, J.J. Van Den Oord, et al. Constitutively activating mutation in WASP causes X-linked severe congenital neutropenia. Nat Genet 27: 313-317, 2001. (Pubitemid 32201854)
41. S. Burns, G.O. Cory, W. Vainchenker, and A.J. Thrasher. Mechanisms of WASp-mediated hematologic and immunologic disease. Blood 104: 3454-3462, 2004. (Pubitemid 39564413)
42. P.J. Ancliff, M.P. Blundell, G.O. Cory, Y. Calle, A. Worth, H. Kempski, et al. Two novel activating mutations in the Wiskott-Aldrich syndrome protein result in congenital neutropenia. Blood 108: 2182-2189, 2006. (Pubitemid 44497498)
43. D.A. Moulding, M.P. Blundell, D.G. Spiller, M.R. White, G.O. Cory, Y. Calle, et al. Unregulated actin polymerization by WASp causes defects of mitosis and cytokinesis in X-linked neutropenia. J Exp Med 204: 2213-2224, 2007. (Pubitemid 47360880)
44. H.D. Ochs and A.J. Thrasher. The Wiskott-Aldrich syndrome. J Allergy Clin Immunol 117: 725-738; quiz 739, 2006. (Pubitemid 44313817)
45. P. Cohen and S. Frame. The renaissance of GSK3. Nat Rev Mol Cell Biol 2: 769-776, 2001. (Pubitemid 33679839)
46. R.E. Person, F.Q. Li, Z. Duan, K.F. Benson, J. Wechsler, H.A. Papadaki, et al. Mutations in proto-oncogene GFI1 cause human neutropenia and target ELA2. Nat Genet 34: 308-312, 2003. (Pubitemid 36792864)
47. T. Moroy, H. Zeng, J. Jin, K.W. Schmid, A. Carpinteiro, and E. Gulbins. The zinc finger protein and transcriptional repressor Gfi1 as a regulator of the innate immune response. Immunobiology 213: 341-352, 2008.
48. H. Hock, M.J. Hamblen, H.M. Rooke, J.W. Schindler, S. Saleque, Y. Fujiwara, and S.H. Orkin. Gfi-1 restricts proliferation and preserves functional integrity of haematopoietic stem cells. Nature 431: 1002-1007, 2004. (Pubitemid 39434423)
49. P.S. Rosenberg, B.P. Alter, A.A. Bolyard, M.A. Bonilla, L.A. Boxer, B. Cham, et al. The incidence of leukemia and mortality from sepsis in patients with severe congenital neutropenia receiving long-term G-CSF therapy. Blood 107: 4628-4635, 2006. (Pubitemid 43882607)
50. F. Dong, R.K. Brynes, N. Tidow, K. Welte, B. Lowenberg, and I.P. Touw. Mutations in the gene for the granulocyte colony-stimulating-factor receptor in patients with acute myeloid leukemia preceded by severe congenital neutropenia.N Engl J Med 333: 487-493, 1995.
51. M. Germeshausen, M. Ballmaier, and K. Welte. Incidence of CSF3R mutations in severe congenital neutropenia and relevance for leukemogenesis: Results of a long-term survey. Blood 109: 93-99, 2007. (Pubitemid 46053048)
52. S.J. Salipante, K.F. Benson, and R.E. Person. Neutropenia-associated mutations of PFAAP5, a novel protein mediating transcriptional repressor interaction between Gfi1 and neutrophil elastase. In:ASH Annual Meeting Abstracts: Blood, p. Abstract 501, 2006.
53. Z. Duan, S.Huang, and R.E. Person. Neutropenia-associated mutations in PRDM5, a novel epigenetic regulator of hematopoiesis. In: ASH Annual Meeting Abstracts: Blood, p. Abstract 503, 2006.
54. N. Berliner,M. Horwitz, and T.P. Loughran, Jr. Congenital and acquired neutropenia. Hematology Am Soc Hematol Educ Program 63-79, 2004.
55. D.C. Dale and W.P.T. Hammond. Cyclic neutropenia: a clinical review. Blood Rev 2: 178-185, 1988.
56. N. Rezaei, A. Farhoudi, Z. Pourpak, A. Aghamohammadi, A. Ramyar, M. Moin, et al. Clinical and laboratory findings in Iranian children with cyclic neutropenia. Iran J Allergy Asthma Immunol 3: 37-40, 2004.
57. Y. Sera, H. Kawaguchi, K. Nakamura, T. Sato, M. Habara, S. Okada, et al. A comparison of the defective granulopoiesis in childhood cyclic neutropenia and in severe congenital neutropenia. Haematologica 90: 1032-1041, 2005. (Pubitemid 41323502)
58. M.S. Horwitz, Z. Duan, B. Korkmaz, H.H. Lee, M.E. Mealiffe, and S.J. Salipante. Neutrophil elastase in cyclic and severe congenital neutropenia. Blood 109: 1817- 1824, 2007. (Pubitemid 46348175)
59. M. Horwitz, K.F. Benson, R.E. Person, A.G. Aprikyan, and D.C. Dale. Mutations in ELA2, encoding neutrophil elastase, define a 21-day biological clock in cyclic haematopoiesis. Nat Genet 23: 433-436, 1999.
60. O.P. Smith, I.M. Hann, J.M. Chessells, B.R. Reeves, and P. Milla. Haematological abnormalities in Shwachman-Diamond syndrome. Br J Haematol 94: 279-284, 1996. (Pubitemid 26247985)
61. Y. Dror, P. Durie, H. Ginzberg, R. Herman, A. Banerjee, M. Champagne, et al. Clonal evolution in marrows of patients with Shwachman-Diamond syndrome: A prospective 5-year follow-up study. Exp Hematol 30: 659-669, 2002. (Pubitemid 34835684)
62. H. Ginzberg, J. Shin, L. Ellis, J. Morrison, W. Ip, Y. Dror, et al. Shwachman syndrome: Phenotypic manifestations of sibling sets and isolated cases in a large patient cohort are similar. J Pediatr 135: 81-88, 1999. (Pubitemid 30180567)
63. Y. Dror. Shwachman-Diamond syndrome. Pediatr Blood Cancer 45: 892-901, 2005. (Pubitemid 41552156)
64. O.P. Smith. Shwachman-Diamond syndrome. Semin Hematol 39: 95-102, 2002. (Pubitemid 34298832)
65. A. Shimamura. Shwachman-Diamond syndrome. Semin Hematol 43: 178-188, 2006. (Pubitemid 43963505)
66. A. Kent, G.H. Murphy, and P. Milla. Psychological characteristics of children with Shwachman syndrome. Arch Dis Child 65: 1349-1352, 1990.
67. P.J. Aggett,N.P. Cavanagh,D.J.Matthew, J.R. Pincott, J. Sutcliffe, and J.T. Harries. Shwachman's syndrome. A review of 21 cases. Arch Dis Child 55: 331-347, 1980.
68. G.R. Boocock, J.A. Morrison, M. Popovic, N. Richards, L. Ellis, P.R. Durie, and J.M. Rommens. Mutations in SBDS are associated with Shwachman-Diamond syndrome. Nat Genet 33: 97-101, 2003. (Pubitemid 36068690)
69. K.M. Austin, M.L. Gupta, S.A. Coats, A. Tulpule, G. Mostoslavsky, A.B. Balazs, et al. Mitotic spindle destabilization and genomic instability in Shwachman- Diamond syndrome. J Clin Invest 118: 1511-1518, 2008. (Pubitemid 351500444)
70. K.A. Ganapathi and A. Shimamura. Ribosomal dysfunction and inherited marrow failure. Br J Haematol 141: 376-387, 2008. (Pubitemid 351521153)
71. W.C. Davis and S.D. Douglas. Defective granule formation and function in the Chediak-Higashi syndrome in man and animals. Semin Hematol 9: 431-450, 1972.
72. T. Abo, J.C. Roder, W. Abo, M.D. Cooper, and C.M. Balch. Natural killer (HNK-1+) cells in Chediak-Higashi patients are present in normal numbers but are abnormal in function and morphology. J Clin Invest 70: 193-197, 1982. (Pubitemid 12090839)
73. D.M. Ward, G.M. Griffiths, J.C. Stinchcombe, and J. Kaplan. Analysis of the lysosomal storage disease Chediak-Higashi syndrome. Traffic 1: 816-822, 2000.
74. D.M.Ward, S.L. Shiflett, and J. Kaplan. Chediak-Higashi syndrome: A clinical and molecular view of a rare lysosomal storage disorder. Curr Mol Med 2: 469-477, 2002. (Pubitemid 34760029)
75. S. Certain, F. Barrat, E. Pastural, F. Le Deist, J. Goyo-Rivas, N. Jabado, et al. Protein truncation test of LYST reveals heterogenous mutations in patients with Chediak-Higashi syndrome. Blood 95: 979-983, 2000. (Pubitemid 30062721)
76. H. Zhao, Y.L. Boissy, Z. Abdel-Malek, R.A. King, J.J. Nordlund, and R.E. Boissy. On the analysis of the pathophysiology of Chediak-Higashi syndrome. Defects expressed by cultured melanocytes. Lab Invest 71: 25-34, 1994. (Pubitemid 24246018)
77. M.D. Barbosa, F.J. Barrat, V.T. Tchernev, Q.A. Nguyen, V.S. Mishra, S.D. Colman, et al. Identification of mutations in two major mRNA isoforms of the Chediak- Higashi syndrome gene in human and mouse. Hum Mol Genet 6: 1091-1098, 1997. (Pubitemid 27308395)
78. R. Clark and G.M. Griffiths. Lytic granules, secretory lysosomes and disease. Curr Opin Immunol 15: 516-521, 2003. (Pubitemid 37130191)
79. J. Kaplan, I. De Domenico, and D.M.Ward. Chediak-Higashi syndrome. Curr Opin Hematol 15: 22-29, 2008. (Pubitemid 350191025)
80. Y. Tomita and T. Suzuki. Genetics of pigmentary disorders. Am J Med Genet C Semin Med Genet 131C: 75-81, 2004. (Pubitemid 39441636)
81. C. Griscelli, A. Durandy, D. Guy-Grand, F. Daguillard, C. Herzog, and M. Prunieras. A syndrome associating partial albinism and immunodeficiency. Am J Med 65: 691-702, 1978. (Pubitemid 9039527)
82. S.M. Wilson, R. Yip, D.A. Swing, T.N. O'Sullivan, Y. Zhang, E.K. Novak, et al. A mutation in Rab27a causes the vesicle transport defects observed in ashen mice. Proc Natl Acad Sci U S A 97: 7933-7938, 2000. (Pubitemid 30460751)
83. J.C. Stinchcombe, D.C. Barral, E.H. Mules, S. Booth, A.N. Hume, L.M. Machesky, et al. Rab27a is required for regulated secretion in cytotoxic T lymphocytes. J Cell Biol 152: 825-834, 2001.
84. D.B. Munafo, J.L. Johnson, B.A. Ellis, S. Rutschmann, B. Beutler, and S.D. Catz. Rab27a is a key component of the secretory machinery of azurophilic granules in granulocytes. Biochem J 402: 229-239, 2007. (Pubitemid 46383420)
85. V. Shotelersuk, E.C. Dell'Angelica, L. Hartnell, J.S. Bonifacino, and W.A. Gahl. A new variant of Hermansky-Pudlak syndrome due to mutations in a gene responsible for vesicle formation. Am J Med 108: 423-427, 2000. (Pubitemid 30162963)
86. M. Huizing, C.D. Scher, E. Strovel, D.L. Fitzpatrick, L.M. Hartnell, Y. Anikster, and W.A. Gahl. Nonsense mutations in ADTB3A cause complete deficiency of the beta3A subunit of adaptor complex-3 and severe Hermansky-Pudlak syndrome type 2. Pediatr Res 51: 150-158, 2002. (Pubitemid 34101328)
87. R.H. Clark, J.C. Stinchcombe, A. Day, E. Blott, S. Booth, G. Bossi, et al. Adaptor protein 3-dependent microtubule-mediated movement of lytic granules to the immunological synapse. Nat Immunol 4: 1111-1120, 2003. (Pubitemid 37428039)
88. S. Fontana, S. Parolini, W. Vermi, S. Booth, F. Gallo, M. Donini, et al. Innate immunity defects in Hermansky-Pudlak type 2 syndrome. Blood 107: 4857-4864, 2006. (Pubitemid 43882638)
89. J. Jung, G. Bohn, A. Allroth, K. Boztug, G. Brandes, I. Sandrock, et al. Identification of a homozygous deletion in the AP3B1 gene causing Hermansky-Pudlak syndrome, type 2. Blood 108: 362-369, 2006. (Pubitemid 43990650)
90. J. Stinchcombe, G. Bossi, and G.M. Griffiths. Linking albinism and immunity: the secrets of secretory lysosomes. Science 305: 55-59, 2004. (Pubitemid 38869367)
91. M. Huizing and W.A. Gahl. Disorders of vesicles of lysosomal lineage: The Hermansky-Pudlak syndromes. Curr Mol Med 2: 451-467, 2002. (Pubitemid 34760028)
92. R. Badolato and S. Parolini. Novel insights from adaptor protein 3 complex deficiency. J Allergy Clin Immunol 120: 735-741; quiz 742-733, 2007. (Pubitemid 47531859)
93. G. Bossi and G.M. Griffiths. CTL secretory lysosomes: Biogenesis and secretion of a harmful organelle. Semin Immunol 17: 87-94, 2005. (Pubitemid 39575984)
94. G. Bohn, A. Allroth, G. Brandes, J. Thiel, E. Glocker, A.A. Schaffer, et al. A novel human primary immunodeficiency syndrome caused by deficiency of the endosomal adaptor protein p14. Nat Med 13: 38-45, 2007. (Pubitemid 46067384)
95. C. Speckmann, J. Rohr, and S. Ehl. Genetic disorders of immune regulation. In: N. Rezaei, A. Aghamohammadi, and L.D. Notarangelo (Eds.). Primary Immunodeficiency Diseases: Definition, Diagnosis and Management. Berlin Heidelberg: Springer-Verlag, pp. 167-194, 2008.
96. D. Teis, N. Taub, R. Kurzbauer, D. Hilber, M.E. de Araujo, M. Erlacher, et al. p14-MP1-MEK1 signaling regulates endosomal traffic and cellular proliferation during tissue homeostasis. J Cell Biol 175: 861-868, 2006. (Pubitemid 44969192)
97. R.J. Gorlin, B. Gelb, G.A. Diaz, K.G. Lofsness, M.R. Pittelkow, and J.R. Fenyk, Jr. WHIM syndrome, an autosomal dominant disorder: clinical, hematological, and molecular studies. Am J Med Genet 91: 368-376, 2000. (Pubitemid 30193934)
98. A.A. Aprikyan, W.C. Liles, J.R. Park, M. Jonas, E.Y. Chi, and D.C. Dale. Myelokathexis, a congenital disorder of severe neutropenia characterized by accelerated apoptosis and defective expression of bcl-x in neutrophil precursors. Blood 95: 320-327, 2000. (Pubitemid 30017259)
99. G.A. Diaz and A.V. Gulino. WHIM syndrome: A defect in CXCR4 signaling. Curr Allergy Asthma Rep 5: 350-355, 2005. (Pubitemid 41683977)
100. A.V. Gulino. WHIM syndrome: A genetic disorder of leukocyte trafficking. Curr Opin Allergy Clin Immunol 3: 443-450, 2003. (Pubitemid 39157331)
101. V. Latger-Cannard, D. Bensoussan, and P. Bordigoni. The WHIM syndrome shows a peculiar dysgranulopoiesis: Myelokathexis. Br J Haematol 132: 669, 2006. (Pubitemid 43381628)
102. M.Wetzler, M. Talpaz, E.S. Kleinerman, A. King, Y.O. Huh, J.U. Gutterman, and R. Kurzrock. A new familial immunodeficiency disorder characterized by severe neutropenia, a defective marrow release mechanism, and hypogammaglobulinemia. Am J Med 89: 663-672, 1990. (Pubitemid 20384326)
103. K. Balabanian, B. Lagane, J.L. Pablos, L. Laurent, T. Planchenault, O. Verola, et al. WHIM syndromes with different genetic anomalies are accounted for by impaired CXCR4 desensitization to CXCL12. Blood 105: 2449-2457, 2005. (Pubitemid 40387045)
104. J. Roland, B.J. Murphy, B. Ahr, V. Robert-Hebmann, V. Delauzun, K.E. Nye, et al. Role of the intracellular domains of CXCR4 in SDF-1-mediated signaling. Blood 101: 399-406, 2003. (Pubitemid 36077555)
105. C. Martin, P.C. Burdon, G. Bridger, J.C. Gutierrez-Ramos, T.J. Williams, and S.M. Rankin. Chemokines acting via CXCR2 and CXCR4 control the release of neutrophils from the bone marrow and their return following senescence. Immunity 19: 583-593, 2003. (Pubitemid 37311439)
106. B.T. Suratt, J.M. Petty, S.K. Young, K.C. Malcolm, J.G. Lieber, J.A. Nick, et al. Role of the CXCR4/SDF-1 chemokine axis in circulating neutrophil homeostasis. Blood 104: 565-571, 2004. (Pubitemid 38900043)
107. C.L. Semerad, F. Liu, A.D. Gregory, K. Stumpf, andD.C. Link. G-CSF is an essential regulator of neutrophil trafficking from the bone marrow to the blood. Immunity 17: 413-423, 2002. (Pubitemid 35223531)
108. A. Valenzuela-Fernandez, T. Planchenault, F. Baleux, I. Staropoli, K. Le-Barillec, D. Leduc, et al. Leukocyte elastase negatively regulates stromal cell-derived factor- 1 (SDF-1]/CXCR4 binding and functions by amino-terminal processing of SDF-1 and CXCR4. J Biol Chem 277: 15677-15689, 2002. (Pubitemid 34967841)
109. L.D. Notarangelo, M. Duse, and A.G. Ugazio. Immunodeficiency with hyper-IgM (HIM). Immunodefic Rev 3: 101-121, 1992.
110. R. Fuleihan, N. Ramesh, R. Loh, H. Jabara, R.S. Rosen, T. Chatila, et al. Defective expression of the CD40 ligand in X chromosome-linked immunoglobulin deficiency with normal or elevated IgM. Proc Natl Acad Sci U S A 90: 2170-2173, 1993. (Pubitemid 23078587)
111. J. Levy, T. Espanol-Boren, C. Thomas, A. Fischer, P. Tovo, P. Bordigoni, et al. Clinical spectrum of X-linked hyper-IgM syndrome. J Pediatr 131: 47-54, 1997. (Pubitemid 27498308)
112. N. Rezaei, A. Aghamohammadi, A. Ramyar, Q. Pan-Hammarstrom, and L. Hammarstrom. Severe congenital neutropenia or hyper-IgM syndrome? A novel mutation of CD40 ligand in a patient with severe neutropenia. Int Arch Allergy Immunol 147: 255-259, 2008.
113. A.R. Hayward, J. Levy, F. Facchetti, L. Notarangelo, H.D. Ochs, A. Etzioni, et al. Cholangiopathy and tumors of the pancreas, liver, and biliary tree in boys with X-linked immunodeficiency with hyper-IgM. J Immunol 158: 977-983, 1997. (Pubitemid 127492679)
114. N. Nagaraj, C. Egwim, and D.G. Adler. X-linked hyper-IgM syndrome associated with poorly differentiated neuroendocrine tumor presenting as obstructive jaundice secondary to extensive adenopathy. Dig Dis Sci 52: 2312-2316, 2007. (Pubitemid 47246521)
115. A. Aruffo, M. Farrington, D. Hollenbaugh, X. Li, A. Milatovich, S. Nonoyama, et al. The CD40 ligand, gp39, is defective in activated T cells from patients with X-linked hyper-IgM syndrome. Cell 72: 291-300, 1993. (Pubitemid 23044943)
116. R.A. Kroczek, D. Graf, D. Brugnoni, S. Giliani, U. Korthuer, A. Ugazio, et al. Defective expression of CD40 ligand on T cells causes "X-linked immunodeficiency with hyper-IgM (HIGM1)". Immunol Rev 138: 39-59, 1994. (Pubitemid 24147415)
117. L. Atarod, A. Aghamohammadi, M. Moin, H. Kanegane, N. Rezaei, K. Rezaei Kalantari, et al. Successful management of neutropenia in a patient with CD40 ligand deficiency by immunoglobulin replacement therapy. Iran J Allergy Asthma Immunol 6: 37-40, 2007. (Pubitemid 46354207)
118. M. Mori, S. Nonoyama, M. Neubauer, T. Mitsuda, K. Kosuge, and S. Yokota. Mutation analysis and therapeutic response to granulocyte colony-stimulating factor in a case of hyperimmunoglobulin M syndrome with chronic neutropenia. J Pediatr Hematol Oncol 22: 288-289, 2000. (Pubitemid 32268319)
119. A. Aghamohammadi, V. Lougaris, A. Plebani, M. Miyawaki, A. Durandy, and L. Hammarstorm. Predominantly antibody deficiencies. In: N. Rezaei, A. Aghamohammadi, and L.D. Notarangelo (Eds.). Primary Immunodeficiency Diseases. Berlin Heidelburg: Springer, pp. 97-130, 2008.
120. A. Aghamohammadi, M. Fiorini, M. Moin, N. Parvaneh, S. Teimourian, M. Yeganeh, et al. Clinical, immunological and molecular characteristics of 37 Iranian patients with X-linked agammaglobulinemia. Int Arch Allergy Immunol 141: 408-414, 2006. (Pubitemid 44783913)
121. M. Moin, A. Aghamohammadi, A. Farhoudi, Z. Pourpak, N. Rezaei, M. Movahedi, et al. X-linked agammaglobulinemia: A survey of 33 Iranian patients. Immunol Invest 33: 81-93, 2004. (Pubitemid 38292598)
122. M.E. Conley and V. Howard. Clinical findings leading to the diagnosis of X-linked agammaglobulinemia. J Pediatr 141: 566-571, 2002. (Pubitemid 35193325)
123. H. Kanegane, H. Taneichi, K. Nomura, T. Futatani, and T. Miyawaki. Severe neutropenia in Japanese patients with x-linked agammaglobulinemia. J Clin Immunol 25: 491-495, 2005. (Pubitemid 41298131)
124. A. Aghamohammadi, T. Cheraghi, N. Rezaei, H. Kanegane, S. Abdollahzede, M. Talaei-Khoei, et al. Neutropenia associated with x-linked agammaglobulinemia in an Iranian referral center. Iran J Allergy Asthma Immunol 8: 43-47, 2009.
125. H.M. Lederman and J.A.Winkelstein. X-linked agammaglobulinemia: An analysis of 96 patients. Medicine (Baltimore) 64: 145-156, 1985. (Pubitemid 15041538)
126. G. Verbruggen, S. De Backer, D. Deforce, P. Demetter, C. Cuvelier, E. Veys, and D. Elewaut. X linked agammaglobulinaemia and rheumatoid arthritis. Ann Rheum Dis 64: 1075-1078, 2005. (Pubitemid 40909527)
127. S. Ferrari, R. Zuntini, V. Lougaris, A. Soresina, V. Sourkova, M. Fiorini, et al. Molecular analysis of the pre-BCR complex in a large cohort of patients affected by autosomal-recessive agammaglobulinemia. Genes Immun 8: 325-333, 2007. (Pubitemid 46888040)
128. L. Yel, Y. Minegishi, E. Coustan-Smith, R.H. Buckley, H. Trubel, L.M. Pachman, et al. Mutations in the mu heavy-chain gene in patients with agammaglobulinemia. N Engl J Med 335: 1486-1493, 1996. (Pubitemid 26376681)
129. S. Tsukada, D.C. Saffran, D.J. Rawlings, O. Parolini, R.C. Allen, I. Klisak, et al. Deficient expression of a B cell cytoplasmic tyrosine kinase in human X-linked agammaglobulinemia. Cell 72: 279-290, 1993. (Pubitemid 23044942)
130. J. Valiaho, C.I. Smith, and M. Vihinen. BTKbase: The mutation database for Xlinked agammaglobulinemia. Hum Mutat 27: 1209-1217, 2006. (Pubitemid 44749723)
131. Y. Minegishi, E. Coustan-Smith, Y.H. Wang, M.D. Cooper, D. Campana, and M.E. Conley. Mutations in the human lambda5/14.1 gene result in B cell deficiency and agammaglobulinemia. J Exp Med 187: 71-77, 1998. (Pubitemid 28044821)
132. Y.Wang, H. Kanegane, O. Sanal, I. Tezcan, F. Ersoy, T. Futatani, and T. Miyawaki. Novel Igalpha (CD79a) gene mutation in a Turkish patient with B cell-deficient agammaglobulinemia. Am J Med Genet 108: 333-336, 2002. (Pubitemid 34225897)
133. A.K. Dobbs, T. Yang, D. Farmer, L. Kager, O. Parolini, and M.E. Conley. Cutting edge: A hypomorphic mutation in Igbeta (CD79b) in a patient with immunodeficiency and a leaky defect in B cell development. J Immunol 179: 2055-2059, 2007.
134. S. Ferrari, V. Lougaris, S. Caraffi, R. Zuntini, J. Yang, A. Soresina, et al.Mutations of the Igbeta gene cause agammaglobulinemia in man.J Exp Med 204: 2047-2051, 2007. (Pubitemid 47360867)
135. Y. Minegishi, J. Rohrer, E. Coustan-Smith, H.M. Lederman, R. Pappu, D. Campana, et al. An essential role for BLNK in human B cell development. Science 286: 1954-1957, 1999. (Pubitemid 129515903)
136. J.E. Farrar, J. Rohrer, and M.E. Conley. Neutropenia in X-linked agammaglobulinemia. Clin Immunol Immunopathol 81: 271-276, 1996. (Pubitemid 26414555)
137. B. Tavil and T. Sipahi. Is neutropenia a clue for early diagnosis of X-linked agammaglobulinemia? Pediatr Hematol Oncol 20: 657-658, 2003. (Pubitemid 37462991)
138. F. Le Deist, D. Moshous, S.J. Howe, A. Nahum, F.D. Kavadas, E. Lavine, et al. Combined T and B cell immunodeficiencies. In: N. Rezaei, A. Aghamohammadi, and L.D. Notarangelo (Eds.). Primary Immunodeficiency Diseases. Heidelberg, Berlin: Springer, pp. 39-95, 2008.
139. G. Cacciapuoti, M. Porcelli, C. Bertoldo, S. Fusco, M. De Rosa, and V. Zappia. Extremely thermophilic and thermostable 5-methylthioadenosine phosphorylase from the archaeon sulfolobus solfataricus. Gene cloning and amino acid sequence determination. Eur J Biochem 239: 632-637, 1996. (Pubitemid 26253034)
140. I. Dalal, E. Grunebaum, A. Cohen, and C.M. Roifman. Two novel mutations in a purine nucleoside phosphorylase (PNP)-deficient patient. Clin Genet 59: 430-437, 2001. (Pubitemid 32605810)
141. R.J. Hallett, S.M. Cronin, G. Morgan, J.A. Duley, L.D. Fairbanks, and
142. A. Fleischman, M.S. Hershfield, S. Toutain, H.M. Lederman, K.E. Sullivan, M.B. Fasano, et al. Adenosine deaminase deficiency and purine nucleoside phosphorylase deficiency in common variable immunodeficiency. Clin Diagn Lab Immunol 5: 399-400, 1998. (Pubitemid 28246465)
143. L.J. Gudas, B. Ullman, A. Cohen, and D.W. Martin, Jr. Deoxyguanosine toxicity in amouse T lymphoma: Relationship to purine nucleoside phosphorylase-associated immune dysfunction. Cell 14: 531-538, 1978. (Pubitemid 9190233)
144. Y. Sidi, I. Gelvan, S. Brosh, J. Pinkhas, and O. Sperling. Guanine nucleotide metabolism in red blood cells: The metabolic basis for GTP depletion in HGPRT and PNP deficiency. Adv Exp Med Biol 253A: 67-71, 1989.
145. H.A. Simmonds, L.D. Fairbanks, G.S. Morris, G. Morgan, A.R. Watson, P. Timms, and B. Singh. Central nervous system dysfunction and erythrocyte guanosine triphosphate depletion in purine nucleoside phosphorylase deficiency. Arch Dis Child 62: 385-391, 1987.
146. A. Worth, A.J. Thrasher, and H.B. Gaspar. Autoimmune lymphoproliferative syndrome: Molecular basis of disease and clinical phenotype. Br J Haematol 133: 124-140, 2006.
147. J.J. Bleesing, M.R. Brown, C. Novicio, D. Guarraia, J.K. Dale, S.E. Straus, and T.A. Fleisher. A composite picture of TcR alpha/beta(+) CD4(-)CD8(-) T cells (alpha/beta-DNTCs) in humans with autoimmune lymphoproliferative syndrome. Clin Immunol 104: 21-30, 2002. (Pubitemid 34856505)
148. U. Lopatin, X. Yao, R.K.Williams, J.J. Bleesing, J.K. Dale, D.Wong, et al. Increases in circulating and lymphoid tissue interleukin-10 in autoimmune lymphoproliferative syndrome are associated with disease expression. Blood 97: 3161-3170, 2001.
149. S.W. Kwon, J. Procter, J.K. Dale, S.E. Straus, and D.F. Stroncek. Neutrophil and platelet antibodies in autoimmune lymphoproliferative syndrome. Vox Sang 85: 307-312, 2003. (Pubitemid 37522605)
150. I.J. Fuss,W. Strober, J.K.Dale, S. Fritz,G.R. Pearlstein, J.M. Puck, et al. Characteristic T helper 2 T cell cytokine abnormalities in autoimmune lymphoproliferative syndrome, a syndrome marked by defective apoptosis and humoral autoimmunity. J Immunol 158: 1912-1918, 1997. (Pubitemid 127469551)
151. J.Wu, J.Wilson, J. He, L. Xiang, P.H. Schur, and J.D. Mountz. Fas ligand mutation in a patient with systemic lupus erythematosus and lymphoproliferative disease. J Clin Invest 98: 1107-1113, 1996. (Pubitemid 26299922)
152. H.J. Chun, L. Zheng,M. Ahmad, J.Wang, C.K. Speirs, R.M. Siegel, et al. Pleiotropic defects in lymphocyte activation caused by caspase-8 mutations lead to human immunodeficiency. Nature 419: 395-399, 2002.
153. J.Wang, L. Zheng, A. Lobito, F.K. Chan, J. Dale, M. Sneller, et al. Inherited human caspase 10 mutations underlie defective lymphocyte and dendritic cell apoptosis in autoimmune lymphoproliferative syndrome type II. Cell 98: 47-58, 1999. (Pubitemid 29331195)
154. O. Makitie, J. Rajantie, and I. Kaitila. Anaemia and macrocytosis- Unrecognized features in cartilage-hair hypoplasia. Acta Paediatr 81: 1026-1029, 1992. (Pubitemid 23044781)
155. S.E. Lux, R.B. Johnston, Jr., C.S. August, B. Say, V.B. Penchaszadeh, F.S. Rosen, and V.A. McKusick. Chronic neutropenia and abnormal cellular immunity in cartilage-hair hypoplasia. N Engl J Med 282: 231-236, 1970.
156. M. Virolainen, E. Savilahti, I. Kaitila, and J. Perheentupa. Cellular and humoral immmunity in cartilage-hair hypoplasia. Pediatr Res 12: 961-966, 1978. (Pubitemid 8398359)
157. O. Makitie, I. Kaitila, and E. Savilahti. Susceptibility to infections and in vitro immune functions in cartilage-hair hypoplasia. Eur J Pediatr 157: 816-820, 1998. (Pubitemid 28460742)
158. O. Makitie, I. Kaitila, and E. Savilahti. Deficiency of humoral immunity in cartilage-hair hypoplasia. J Pediatr 137: 487-492, 2000.
159. O. Makitie, E. Marttinen, and I. Kaitila. Skeletal growth in cartilage-hair hypoplasia. A radiological study of 82 patients. Pediatr Radiol 22: 434-439, 1992.
160. O. Makitie, M. Heikkinen, I. Kaitila, and R. Rintala. Hirschsprung's disease in cartilage-hair hypoplasia has poor prognosis. J Pediatr Surg 37: 1585-1588, 2002. (Pubitemid 35253599)
161. M. Ridanpaa, H. van Eenennaam, K. Pelin, R. Chadwick, C. Johnson, B. Yuan, et al. Mutations in the RNA component of RNase MRP cause a pleiotropic human disease, cartilage-hair hypoplasia. Cell 104: 195-203, 2001. (Pubitemid 32174836)
162. R. Gitzelmann and N.U. Bosshard. Defective neutrophil and monocyte functions in glycogen storage disease type Ib: A literature review. Eur J Pediatr 152(Suppl 1): S33-S38, 1993. (Pubitemid 23134775)
163. B.Z. Garty, S.D. Douglas, and Y.L. Danon. Immune deficiency in glycogen storage disease type 1B. Isr J Med Sci 32: 1276-1281, 1996. (Pubitemid 27042457)
164. J.P. Rake, G. Visser, P. Labrune, J.V. Leonard, K. Ullrich, and G.P. Smit. Glycogen storage disease type I: Diagnosis, management, clinical course and outcome. Results of the European Study on Glycogen Storage Disease Type I (ESGSD I). Eur J Pediatr 161(Suppl 1): S20-S34, 2002.
165. J.Y. Chou, D. Matern, B.C. Mansfield, and Y.T. Chen. Type I glycogen storage diseases: Disorders of the glucose-6-phosphatase complex. Curr Mol Med 2: 121-143, 2002. (Pubitemid 34649836)
166. K.J. Lei, H. Chen, C.J. Pan, J.M. Ward, B. Mosinger, Jr., E.J. Lee, et al. Glucose-6- phosphatase dependent substrate transport in the glycogen storage disease type- 1a mouse. Nat Genet 13: 203-209, 1996. (Pubitemid 26000441)
167. H. Hiraiwa, C.J. Pan, B. Lin, S.W. Moses, and J.Y. Chou. Inactivation of the glucose 6-phosphate transporter causes glycogen storage disease type 1b.J Biol Chem 274: 5532-5536, 1999. (Pubitemid 29109201)
168. A.S. Lee. The glucose-regulated proteins: Stress induction and clinical applications. Trends Biochem Sci 26: 504-510, 2001. (Pubitemid 32735452)
169. S.Y. Kim, H.S. Jun, P.A. Mead, B.C. Mansfield, and J.Y. Chou. Neutrophil stress and apoptosis underlie myeloid dysfunction in glycogen storage disease type Ib. Blood 111: 5704-5711, 2008.
170. R.I. Kelley, J.P. Cheatham, B.J. Clark, M.A. Nigro, B.R. Powell, G.W. Sherwood, et al. X-linked dilated cardiomyopathy with neutropenia, growth retardation, and 3-methylglutaconic aciduria. J Pediatr 119: 738-747, 1991.
171. M.M. Mazzocco and R.I. Kelley. Preliminary evidence for a cognitive phenotype in Barth syndrome. Am J Med Genet 102: 372-378, 2001. (Pubitemid 32778024)
172. P.G. Barth, F. Valianpour, V.M. Bowen, J. Lam, M. Duran, F.M. Vaz, and R.J. Wanders. X-linked cardioskeletal myopathy and neutropenia (Barth syndrome): An update. Am J Med Genet A 126A: 349-354, 2004. (Pubitemid 38541803)
173. P.G. Barth, C. Van den Bogert, P.A. Bolhuis, H.R. Scholte, A.H. van Gennip, R.B. Schutgens, and A.G. Ketel. X-linked cardioskeletal myopathy and neutropenia (Barth syndrome): Respiratory-chain abnormalities in cultured fibroblasts. J Inherit Metab Dis 19: 157-160, 1996. (Pubitemid 26137512)
174. S. Bione, P. D'Adamo, E. Maestrini, A.K. Gedeon, P.A. Bolhuis, and D. Toniolo. A novel X-linked gene, G4.5. is responsible for Barth syndrome. Nat Genet 12: 385-389, 1996. (Pubitemid 26106250)
175. T.W. Kuijpers, N.A. Maianski, A.T. Tool, K. Becker, B. Plecko, F. Valianpour, et al. Neutrophils in Barth syndrome (BTHS) avidly bind annexin-V in the absence of apoptosis. Blood 103: 3915-3923, 2004. (Pubitemid 38596313)
176. B.P. Alter. Diagnosis, genetics, and management of inherited bone marrow failure syndromes. Hematology Am Soc Hematol Educ Program 2007: 29-39, 2007.
177. I. Dokal. Dyskeratosis congenita in all its forms. Br J Haematol 110: 768-779, 2000.
178. N.S. Heiss, S.W. Knight, T.J. Vulliamy, S.M. Klauck, S. Wiemann, P.J. Mason, et al. X-linked dyskeratosis congenita is caused by mutations in a highly conserved gene with putative nucleolar functions. Nat Genet 19: 32-38, 1998. (Pubitemid 28242019)
179. T.J. Vulliamy, A. Marrone, S.W. Knight, A. Walne, P.J. Mason, and I. Dokal. Mutations in dyskeratosis congenita: Their impact on telomere length and the diversity of clinical presentation. Blood 107: 2680-2685, 2006.
180. T.J. Vulliamy, A.Walne, A. Baskaradas, P.J. Mason, A. Marrone, and I. Dokal. Mutations in the reverse transcriptase component of telomerase (TERT) in patients with bone marrow failure. Blood Cells Mol Dis 34: 257-263, 2005. (Pubitemid 40693563)
181. A.J. Walne, T. Vulliamy, A. Marrone, R. Beswick, M. Kirwan, Y. Masunari, et al. Genetic heterogeneity in autosomal recessive dyskeratosis congenita with one subtype due to mutations in the telomerase-associated protein NOP10. Hum Mol Genet 16: 1619-1629, 2007. (Pubitemid 47050675)
182. T. Vulliamy and I. Dokal. Dyskeratosis congenita. Semin Hematol 43: 157-166, 2006. (Pubitemid 43977822)
183. M. Roper, R.T. Parmley,W.M. Crist, D.R. Kelly, and M.D. Cooper. Severe congenital leukopenia (reticular dysgenesis). Immunologic and morphologic characterizations of leukocytes. Am J Dis Child 139: 832-835, 1985. (Pubitemid 15022984)
184. R.J. Haas, D. Niethammer, S.F. Goldmann, W. Heit, U. Bienzle, and E. Kleihauer. Congenital immunodeficiency and agranulocytosis (reticular dysgenesia). Acta Paediatr Scand 66: 279-283, 1977. (Pubitemid 8085677)
185. U. Pannicke, M. Honig, I. Hess, C. Friesen, K. Holzmann, E.M. Rump, et al. Reticular dysgenesis (aleukocytosis) is caused by mutations in the gene encoding mitochondrial adenylate kinase 2. Nat Genet 41: 101-105, 2009.
186. C. Lagresle-Peyrou, E.M. Six, C. Picard, F. Rieux-Laucat, V. Michel, A. Ditadi, et al. Human adenylate kinase 2 deficiency causes a profound hematopoietic defect associated with sensorineural deafness. Nat Genet 41: 106-111, 2009.
187. S. Kivitie-Kallio and R. Norio. Cohen syndrome: Essential features, natural history, and heterogeneity. Am J Med Genet 102: 125-135, 2001. (Pubitemid 32674983)
188. S. Kivitie-Kallio, J. Rajantie, E. Juvonen, and R. Norio. Granulocytopenia in Cohen syndrome. Br J Haematol 98: 308-311, 1997. (Pubitemid 27345102)
189. S. Alaluusua, S. Kivitie-Kallio, J. Wolf, M.L. Haavio, S. Asikainen, and S. Pirinen. Periodontal findings in Cohen syndrome with chronic neutropenia. J Periodontol 68: 473-478, 1997. (Pubitemid 127521202)
190. O. Olivieri, S. Lombardi, C. Russo, and R. Corrocher. Increased neutrophil adhesive capability in Cohen syndrome, an autosomal recessive disorder associated with granulocytopenia. Haematologica 83: 778-782, 1998. (Pubitemid 28496165)
191. J. Kolehmainen, G.C. Black, A. Saarinen, K. Chandler, J. Clayton-Smith, A.L. Traskelin, et al. Cohen syndrome is caused by mutations in a novel gene, COH1, encoding a transmembrane protein with a presumed role in vesicle-mediated sorting and intracellular protein transport. Am J Hum Genet 72: 1359-1369, 2003. (Pubitemid 36628377)
192. A. Velayos-Baeza, A. Vettori, R.R. Copley, C. Dobson-Stone, and A.P.Monaco. Analysis of the human VPS13 gene family. Genomics 84: 536-549, 2004. (Pubitemid 39037164)
193. D.C. Dale, T.E. Cottle, C.J. Fier, A.A. Bolyard, M.A. Bonilla, L.A. Boxer, et al. Severe chronic neutropenia: Treatment and follow-up of patients in the Severe Chronic Neutropenia International Registry. Am J Hematol 72: 82-93, 2003. (Pubitemid 36164341)
194. D.C. Dale, M.A. Bonilla, M.W. Davis, A.M. Nakanishi, W.P. Hammond, J. Kurtzberg, et al. A randomized controlled phase III trial of recombinant human granulocyte colony-stimulating factor (filgrastim) for treatment of severe chronic neutropenia. Blood 81: 2496-2502, 1993. (Pubitemid 23147550)
195. M.A. Bonilla, A.P. Gillio, M. Ruggeiro, N.A. Kernan, J.A. Brochstein, M. Abboud, et al. Effects of recombinant human granulocyte colony-stimulating factor on neutropenia in patients with congenital agranulocytosis. N Engl J Med 320: 1574-1580, 1989. (Pubitemid 19154570)
196. N. Berliner. Lessons from congenital neutropenia: 50 years of progress in understanding myelopoiesis. Blood 111: 5427-5432, 2008.
197. B.I. Lord, M.H. Bronchud, S. Owens, J. Chang, A. Howell, L. Souza, and T.M. Dexter. The kinetics of human granulopoiesis following treatment with granulocyte colony-stimulating factor in vivo. Proc Natl Acad Sci U S A 86: 9499-9503, 1989. (Pubitemid 20010454)
198. P. Anderlini, D. Przepiorka, R. Champlin, and M. Korbling. Biologic and clinical effects of granulocyte colony-stimulating factor in normal individuals. Blood 88: 2819-2825, 1996. (Pubitemid 26357361)
199. J.H. Rex, S.C. Bhalla, D.M. Cohen, J.P. Hester, S.E. Vartivarian, and E.J. Anaissie. Protection of human polymorphonuclear leukocyte function from the deleterious effects of isolation, irradiation, and storage by interferon-gamma and granulocytecolony- stimulating factor. Transfusion 35: 605-611, 1995.
200. N.A. Maianski, F.P. Mul, J.D. van Buul, D. Roos, and T.W. Kuijpers. Granulocyte colony-stimulating factor inhibits the mitochondria-dependent activation of caspase-3 in neutrophils. Blood 99: 672-679, 2002. (Pubitemid 34533107)
201. M.H. Freedman, M.A. Bonilla, C. Fier, A.A. Bolyard, D. Scarlata, L.A. Boxer, et al. Myelodysplasia syndrome and acute myeloid leukemia in patients with congenital neutropenia receiving G-CSF therapy. Blood 96: 429-436, 2000. (Pubitemid 30463359)
202. C. Zeidler, K. Welte, Y. Barak, F. Barriga, A.A. Bolyard, L. Boxer, et al. Stem cell transplantation in patients with severe congenital neutropenia without evidence of leukemic transformation. Blood 95: 1195-1198, 2000. (Pubitemid 30099826)